Document is current
Any future updates will be listed below
-
Authors
Canelo-Vilaseca, Marta
Sabbah, Mohamad
Di Blasi, Roberta
Cristinelli, Caterina
Sureda, Anna https://orcid.org/0000-0002-1238-6970
Caillat-Zucman, Sophie https://orcid.org/0000-0002-4535-3550
Thieblemont, Catherine https://orcid.org/0000-0002-9941-2448
- License Information
-
More Information
Article History
Received: 10 August 2024
Revised: 29 September 2024
Accepted: 17 February 2025
First Online: 27 March 2025
Competing interests
: MCV: no COI. MS: no conflict of interest. RdiB: Honoraria for boards, conferences and travellings: Roche, Kyte/Gilead, Novartis, BMS. CC: no COI. AS Honoraria for boards, conferences and travellings: Roche, Kyte/Gilead, Novartis, BMS. SC-Z no COI. CT Honoraria for boards, conferences and travellings: Roche, Kyte/Gilead, Novartis, BMS, Incyte, Amgen.
